Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. de Vries, J. van der Maten, P. J. Sterk, A. Ten Brinke (Leeuwarden, Amsterdam, Netherlands). Repeated eNose assessment in the monitoring of O₂-induced changes in exhaled breath metabolites in COPD. Eur Respir J 2008; 32: Suppl. 52, 1568

Member's Comments

No comment yet.

Related content which might interest you: Exhaled breath CO and induced sputum in noninvasive assessment of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002 Technical problems with measurements of biomarkers - exhaled breath condensate Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients Source: International Congress 2017 – Management of COPD Year: 2017 Increased nitrosative stress in COPD airways: validation and measurement in exhaled breath condensate Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath Source: ERS Lung Science Conference 2016 Year: 2016 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Possible use of exhaled breath condensate (EBC) for continuous monitoring of lung inflammation in artificial ventilation Source: Eur Respir J 2002; 20: Suppl. 38, 85s Year: 2002 Reproducibility of cysteinyl-leukotriene measurements in exhaled breath condensate in children Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 Exhaled breath condensate pH standardised for CO2 partial pressure Source: Eur Respir J 2007; 29: 496-501 Year: 2007 Comparison of two devices and two breathing patterns for exhaled breath condensate sampling Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010 Alcohol metabolites are detectable in exhaled breath of healthy, unaffected by a breath holding maneuver and may serve as novel pro-inflammatory biomarkers in asthma and COPD Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate Source: Annual Congress 2007 - Acute and chronic effects of air pollution Year: 2007